🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of the study is to find out if, after 4 weeks of dosing, s...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00454298
Treatments Being Tested
This study will evaluate the pharmacokinetics (area under the curve \[AUC\]...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT02864199
Treatments Being Tested
Traditional management of community-acquired pneumonia (CAP) relies on the ...
Status
Completed
Location
4th Department of Internal Medicine, Attikon University Hospital
Start Date
2021-01-25
Trial ID
NCT04724044
Treatments Being Tested
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
Double-blind randomized placebo-controlled clinical trial with two parallel...
Status
Recruiting
Location
Elisabet Palomera
Start Date
2025-06-10
Trial ID
NCT06925880
Treatments Being Tested
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
The goal of this project is to observe the benefits induced by physical act...
Status
Completed
Location
SPORMED
Start Date
2020-11-01
Trial ID
NCT06651125
Treatments Being Tested
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
A prospective open-label phase 2 study will be designed to assess the effic...
Status
Unknown
Location
The University of Hong Kong
Start Date
2021-01-01
Trial ID
NCT04689815
Treatments Being Tested